N.L. Mason

Alnagger, N. L. N., Cardone, P., Martial, C., Perl, Y. S., Mindlin, I., Sitt, J. D., Roseman, L., Carhart-harris, R., Nutt, D., Mallaroni, P., Mason, N., Ramaekers, J. G., Bonhomme, V., Laureys, S., Deco, G., Gosseries, O., Nunez, P., & Annen, J. (2026). A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness. Advanced Science, 13(11), Article e11780. https://doi.org/10.1002/advs.202511780

Mallaroni, P., Singleton, S. P., Mason, N. L., Satterthwaite, T. D., & Ramaekers, J. G. (2026). Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin. Molecular Psychiatry. Advance online publication. https://doi.org/10.1038/s41380-026-03447-0

Ramaekers, J. G., Mallaroni, P., Mason, N. L., & Avram, M. (2025). Not all psychedelics are created equal. Nature Mental Health, 3(12), 1465-1467. https://doi.org/10.1038/s44220-025-00551-y

Prevete, E., Mason, N. L., Kuypers, K. P. C., Theunissen, E. L., Mallaroni, P., Pasquini, M., & Ramaekers, J. G. (2025). Use patterns of classic, novel, and herbal opioids. Emerging Trends in Drugs, Addictions, and Health, 5, Article 100166. https://doi.org/10.1016/j.etdah.2024.100166

Cavarra, M., Hutten, N. R. P. W., Schepers, J., Mason, N. L., Theunissen, E. L., Liechti, M. E., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2025). A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 µg) on pain perception in healthy volunteers. British Journal of Pain, 19(6), 434-445. https://doi.org/10.1177/20494637251371626

Lege, K. S., Mallaroni, P., Mortaheb, S., Mason, N. L., Theunissen, E. L., Tse, D. H. Y., Toennes, S. W., Demertzi, A., & Ramaekers, J. G. (2025). Cannabis Perturbs Dynamic Brain States. Biological Psychiatry. Advance online publication. https://doi.org/10.1016/j.biopsych.2025.10.015

Ramaekers, J. G., Reckweg, J. T., Mason, N. L., Kuypers, K. P. C., Toennes, S. W., & Theunissen, E. L. (2025). Low to moderate doses of 3-methylmethcathinone (3-MMC) produce analgesic effects in healthy volunteers: a proof of principle study with a designer drug. Psychopharmacology, 242(10), 2293-2301. https://doi.org/10.1007/s00213-025-06798-8

Rossi, G. N., Khubsing, R. S. I., Haijen, E. C. H. M., Mason, N. L., van Leerdam, M., dos Santos, R. G., Hallak, J. E. C., & Kuypers, K. P. C. (2025). Comparative effects of ayahuasca and breathwork on self-reported cognitive flexibility, emotion regulation, positive affect, and sleep quality. Journal of Psychedelic Studies. Advance online publication. https://doi.org/10.1556/2054.2025.00440

Alnagger, N., Cardone, P., Martial, C., Sanz Perl, Y., Mindlin, I., Sitt, J. D., Roseman, L., Carhart-Harris, R., Nutt, D., Mallaroni, P., Mason, N., Ramaekers, J. G., Bonhomme, V., Laureys, S., Deco, G., Gosseries, O., Nunez, P., & Annen, J. (2025). A Virtual Clinical Trial of Psychedelics for Disorders of Consciousness. Brain Injury, 39(S1), S143-S144.

Reckweg, J. T., Mason, N. L., Theunissen, E. L., Svendsen, C. B., Terwey, T. H., & Ramaekers, J. G. (2025). Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT. Frontiers in Psychology, 16, Article 1543640. https://doi.org/10.3389/fpsyg.2025.1543640